The case for cross-over trials in phase III

Stat Med. 1997 Sep 15;16(17):2021-2. doi: 10.1002/(sici)1097-0258(19970915)16:17<2021::aid-sim644>3.0.co;2-e.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Clinical Trials, Phase III as Topic / methods*
  • Cross-Over Studies*
  • Humans
  • Random Allocation
  • Research Design